CapsoVision CV
NASDAQ CV
$5.91 -0.21 (-3.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

CapsoVision (CV) Assets (2024 - 2026)

CapsoVision (CV) posted Assets of $18.2 million for Q4 2025, down 29.22% sequentially from $25.7 million in Q3 2025, and up 8.1% YoY from $16.8 million in Q4 2024.

CapsoVision (CV) Assets (2024 - 2026) Analysis & Trends

CapsoVision has reported Assets for 2 years, with the latest figure at $18.2 million in Q4 2025.

  • Quarterly Assets rose 8.1% year-over-year to $18.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.2 million (up 8.1% YoY) and the FY2025 annual result came in at $18.2 million, up 8.1% from the prior year.
  • Assets retreated to $18.2 million in Q4 2025 per CV's latest filing, from $25.7 million in the prior quarter.
  • Over five years, Assets peaked at $25.7 million in Q3 2025 and troughed at $9.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 CapsoVision 295.13 Mn 286.05 Mn 1.87 Mn 18.57 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 18.57 Mn
Dec 31, 2025 18.16 Mn
Sep 30, 2025 25.66 Mn
Jun 30, 2025 9.55 Mn
Dec 31, 2024 16.80 Mn